Jose Egidio Paulo de Oliveira
Overview
Explore the profile of Jose Egidio Paulo de Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leao I, Dantas J, Araujo D, Ramos M, Silva K, Batista L, et al.
Diabetol Metab Syndr
. 2024 May;
16(1):114.
PMID: 38790009
Background: Mesenchymal stem cell infusion and vitamin D supplementation may have immunomodulatory actions that could prolong the preservation of residual insulin secretion in patients with type 1 diabetes (T1D). Intervention...
2.
Dantas J, Araujo D, Silva K, Souto D, Pereira M, Raggio L, et al.
Horm Metab Res
. 2023 May;
55(8):536-545.
PMID: 37192655
To evaluate safety and therapeutic effect along 12 months of allogenic adipose tissue-derived stromal/stem cells (ASCs) transplantation with cholecalciferol (VITD) in patients with recent-onset type 1 diabetes (T1D). Prospective, phase...
3.
Dantas J, Araujo D, Silva K, Souto D, Pereira M, Luiz R, et al.
Arch Endocrinol Metab
. 2021 May;
65(3):342-351.
PMID: 33939911
Objective: Adipose tissue-derived stromal/stem cells (ASCs) and vitamin D have immunomodulatory actions that could be useful for type 1 diabetes (T1D). We aimed in this study to investigate the safety...
4.
Magno F, Medeiros de Sousa P, Rodrigues M, Pereira L, de Oliveira J, Lopes Rosado E, et al.
Arch Endocrinol Metab
. 2018 May;
62(3):346-351.
PMID: 29791656
Objective: Roux-en-Y gastric bypass (RYGB) reduces body weight and the comorbidities associated with obesity. The aim of this study was to evaluate whether glucose and lipid profiles were maintained during...
5.
Parisi M, Neto A, Menezes F, Gomes M, Teixeira R, de Oliveira J, et al.
Diabetol Metab Syndr
. 2016 Mar;
8:25.
PMID: 26989446
Background: Studies on diabetic foot and its complications involving a significant and representative sample of patients in South American countries are scarce. The main objective of this study was to...
6.
Araujo D, Barone B, Melleti N, Dantas J, Oliveira M, Zajdenverg L, et al.
Arch Endocrinol Metab
. 2015 May;
59(2):112-5.
PMID: 25993672
Objective: Thyroid diseases are common in individuals with type 1 diabetes mellitus (T1DM) and should be investigated annually in these individuals. The aim of this study was to evaluate the...
7.
Araujo D, Skarstrand H, Barone B, Dantas J, Kupfer R, Zajdenverg L, et al.
Arq Bras Endocrinol Metabol
. 2014 Nov;
58(7):737-43.
PMID: 25372583
Objective: Zinc transporter 8 autoantibodies (ZnT8A) have been poorly studied in non-Caucasian individuals. We aimed to investigate the prevalence of ZnT8 autoantibodies in patients with T1D and their first degree...
8.
Pinto A, Dantas J, Araujo D, Barone B, Papi J, de Oliveira J, et al.
Diabetes Res Clin Pract
. 2013 Oct;
102(2):e41-3.
PMID: 24083984
Anti-parietal cell (APC) antibodies and pernicious anemia (PA) were evaluated in patients with type 1 diabetes (n=75) and in controls. A higher frequency of APC (13.3%) and PA (4%) was...
9.
Almeida M, Dantas J, Barone B, Serfaty F, Kupfer R, Albernaz M, et al.
Clinics (Sao Paulo)
. 2013 Feb;
68(1):123-6.
PMID: 23420171
Objective: To evaluate serum C-peptide in 88 patients from a multiethnic population with Type-1 diabetes and variable disease durations. Method: Eighty-eight patients with a mean disease duration of 8.1 +7.6...
10.
Young E, Pires M, Marques L, de Oliveira J, Zajdenverg L
Diabetes Metab Syndr
. 2012 Jul;
5(3):137-42.
PMID: 22813566
Controversy exists regarding the effect of pregnancy on the development and course of diabetic nephropathy. This study followed 43 pregnant women with previous diabetes mellitus, 32 without nephropathy (Group I)...